Perez Algorta, Guillermo Daniel and van Meter, Anna and Dubicka, Bernadka and Jones, Steven Huntley and Youngstrom, Eric A. and Lobban, Anne Fiona (2018) Blue Blocking Glasses Worn at Night in First Year Higher Education Students with Sleep Complaints : A Feasibility Study. Pilot and Feasibility Studies, 4: 166. ISSN 2055-5784
_Amber_Paper_plain_text_submission2.pdf - Accepted Version
Available under License Creative Commons Attribution.
Download (477kB)
Abstract
Background: Late adolescence and early adulthood is a period of highest incidence for onset of mental health problems. Transition to college environment has been associated with many risk factors such as the initial disruption - and subsequent irregularity - of the student's sleep and activity schedule. We tested the feasibility of using blue blocking glasses (BBG) at night in first year higher education students with sleep complaints, to obtain preliminary evidence for the impact of BBG on sleep, activity and mood. Methods: Participants were thirteen first year undergraduates (from 10 different academic courses) living on campus for first time with sleep complaints/disorders confirmed at screening via the Duke Structured Interview Schedule for Sleep Disorders. We used a two-week, balanced crossover design (BBG vs placebo glasses; participants were unaware which was the active intervention) with computer-generated random allocation. Exploratory analyses provided descriptive and frequency summaries to evaluate feasibility of the intervention. Results: Preliminary evidence supports the feasibility and acceptability of the trial; almost all screened participants consented and completed the protocol with high adherence, missing data were negligible. Additionally, the effectiveness of BBGs to enhance sleep, mood and activity levels in young adults was supported. Conclusions: The results of this feasibility trial suggest that BBG have potential as an inexpensive and feasible intervention for reducing sleep and circadian dysregulation in young adult students. A larger trial, following this successfully-implemented protocol, is necessary to fully test the efficacy of BBG.